Search
for

    Sort by

    Research 571–600 of 1000+

    1. Low-Dose Dimethyl Sulfoxide (DMSO) Suppresses Androgen Receptor (AR) and Its Splice Variant AR-V7 in Castration-Resistant Prostate Cancer (CRPC) Cells Therapeutics · 2025
    2. Remediation of prostrate-related disorders using polyphenols: kolaviron and quercetin in perspective KIU journal of health science · 2024
    3. Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses PLoS medicine · 2024
    4. Fluxactive Complete (#1 PREMIUM PROSTATE SUPPORT FORMULA) Managing Prostate Wellness And Bladder Functions! Zenodo (CERN European Organization for Nuclear Research) · 2022
    5. Identification of seven new prostate cancer susceptibility loci through a genome-wide association study UNC Libraries · 2020
    6. 5α- Reductase Inhibitors in Prostate Cancer: An Overview Austin Journal of Cancer and Clinical Research · 2017
    7. Finasteride para disminuir el sangrado en resección transuretral de próstata en pacientes con sonda Foley Revista del Hospital Juárez de México · 2014
    8. Photoacoustic imaging for prostate brachytherapy cIRcle (University of British Columbia) · 2014
    9. Finasteride and prostate cancer 2011
    10. Management of Advanced Prostate Cancer Undergoing Major Shift Oncology times · 2011
    11. 412 DETECTION OF CIRCULATING PROSTATE CANCER CELLS BY MEANS OF AN ANTIBODY-CONJUGATED NANOPARTICULAR BIOSENSOR European Urology Supplements · 2011
    12. Risk factors for prostate cancer: a case-control study investigating selected key exposures and their interactions with predisposition genes Jurnal Natural (Faculty of Mathematics and Natural Science, Syiah Kuala University) · 2010
    13. Efecto en el sangrado perioperatorio durante la resección transuretral de la próstata tras un mes de tratamiento con dutasteride Actas Urológicas Españolas · 2010
    14. Urological Oncology: Prostate Cancer 2010
    15. Slow progress in prostate cancer BJUI · 2007
    16. How not to detect prostate cancer Lancet Oncology · 2007
    17. Effects of the androgen receptor overexpression in prostate cancer 2007
    18. TRAIL sensitization of PC3 prostate cancer cells by doxorubicin can be blocked by the anti-oxidant N-acetyl-cysteine or by the iron chelator deferoxamine Clinical Cancer Research · 2006
    19. Doxetaxel: new indication. Prostate cancer: a few more weeks. PubMed · 2006
    20. RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER 2005
    21. Can we predict prostate size by scoring baldness? The relationship of androgenic alopecia and lower urinary tract symptoms Central European Journal of Urology · 2019
    22. 5α-reductase activity in the prostate Urology · 2001 · 237 citations
    23. Androgen biosynthetic pathways in the human prostate 2008 · 160 citations
    24. Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients The American Journal of Medicine · 1992 · 116 citations
    25. Prospective investigation of risk factors for prostate cancer in the UK Biobank cohort study British Journal of Cancer · 2017 · 65 citations
    26. Five-alpha-reductase Inhibitors for prostate cancer prevention. The Cochrane library · 2008 · 37 citations
    27. Androgenetic alopecia and risk of prostate cancer: A systematic review and meta-analysis Journal of The American Academy of Dermatology · 2013 · 34 citations
    28. Postscreening follow-up of the Finnish Prostate Cancer Screening Trial on putative prostate cancer risk factors: vitamin and mineral use, male pattern baldness, pubertal development and non-steroidal anti-inflammatory drug use Scandinavian journal of urology · 2016 · 29 citations
    29. Key targets of hormonal treatment of prostate cancer. Part 2: the androgen receptor and 5α-reductase BJU international · 2009 · 29 citations
    30. Estimating the Contribution of the Prostate to Blood Dihydrotestosterone 2003 · 28 citations